establishing safety and care requirements for clinician-administered drugs.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 50 Sponsors

Ought to Pass with Amendment Sep 17, 2026 · 872 words Open full page ↗

SB 256-FN - AS AMENDED BY THE SENATE

01/07/2026 3029s

2025 SESSION

25-1003

05/11

SENATE BILL 256-FN

AN ACT establishing safety and care requirements for clinician-administered drugs.

SPONSORS: Sen. McGough, Dist 11; Sen. Gannon, Dist 23; Sen. Rochefort, Dist 1; Rep. Potucek, Rock. 13; Rep. Miles, Hills. 12

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

30.3% Uncertain

Why this number

Stage base Passed First Chamber — base rate 50%, measured from NH's completed sessions
Momentum +2 57/100 from the pace of recorded action
Time since last action -21 149 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.